Название продукции:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

IUPAC Name:2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

CAS:90213-66-4
Молекулярная формула:C6H3Cl2N3
Чистота:98%
Номер в каталоге:CM103618
Молекулярная масса:188.01

Упаковочная единица Доступно для заказа Цена ($) Количество
CM103618-100g in stock ijƴ
CM103618-500g in stock řřţ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:90213-66-4
Молекулярная формула:C6H3Cl2N3
Точка плавления:-
Smiles-код:ClC1=NC(Cl)=C2C=CNC2=N1
Плотность:
Номер в каталоге:CM103618
Молекулярная масса:188.01
Точка кипения:
Номер Mdl:MFCD08059278
Хранение:-20°C

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.

Column Infos

Capivasertib
On November 16, FDA approved Capivasertib for the treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative locally advanced or metastatic breast cancer. Capivasertib is a highly selective inhibitor targeting three AKT subtypes (AKT1/2/3), which can block signals used by cancer cells for division and growth.